BI, Dicerna to develop RNAi therapeutics for liver disease

3rd November 2017 Uncategorised 0

Boehringer Ingelheim has linked with US group Dicerna Pharmaceuticals to develop new RNAi therapeutics for liver diseases.

More: BI, Dicerna to develop RNAi therapeutics for liver disease
Source: News